> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# De Novo for Onkos Implant Antibacterial Coating
- URL: https://www.fdaweb.com/de-novo-for-onkos-implant-antibacterial-coating/
- Published: 2024-06-20T12:00:00.000Z
- Updated: 2026-09-14T14:33:45.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5157223

FDA has granted Onkos Surgical a de novo authorization for its novel antibacterial coating for use with implants. “Implant contamination is a growing concern to the orthopedic surgical community,” the company says. The coating technology was authorized based on data showing that the “proprietary coating does not elute and has been proven to be bactericidal, with a 99.999% (5 log) kill rate in *in-vitro* testing of bacteria that are commonly found in the operating room environment,” it adds.